|||||Page|
|---|---|---|---|---|
|Report ofthe|Trustees|||1to 9|
|Report ofthe|Independent|Auditors||10to 12|
|Consolidated|Statement of|Financial|Activities|13|
|Consolidated|Balance Sheet|||14|
|Company<br>Balance Sheet||||15|
|Consolidated|Cash Flow Statement|||16to 17|
|Notes to the|Financial Statements|||18to 2B|
|Detailed Statement of Financial<br>Activities||||29|





## 



## 

## 

## 

## 

## 



## 

## 

## 



## 



## 

## 

## 

|||2021/22|2020/21|
|---|---|---|---|
|Total patients||96|77|
|Number<br>ofhours ofgeneral care|provided|9,224|9,866|
|Additional<br>hours ofrespite/night|sits provided|1,530|940|
|Total number of hours ofcare provided||10,754|10,806|



## 



## 

## 



## 

## 

## 



## 



## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 



## 



## 

|||||||31.3.22|31.3.21|
|---|---|---|---|---|---|---|---|
|||||Unrestricted|Restricted|Total|Tata I|
|||||funds|funds|funds|Funds|
||||Notes|E|E|E|E|
|Income from:||||||||
|Donations<br>and legacies|||2|386,903||386,903|138,013|
|Charitable<br>activities:||||||||
|Grants||||425p513|143,478|568p991|851,244|
|Other||||6,034||6,034|37,947|
|Other trading activities||||272,501||272,501|141,041|
|Investments||||345||345|798|
|TOTAL||||1,091,296|143,478|1,234,774|1,169,043|
|Expenditure<br>on:||||||||
|Raising funds||||||||
|Trading and marketing||||65,915||65p915|41,897|
|Fundraising||||78,795||78,795|44,696|
|Charitable<br>activities||||685,349|145,468|830,817|869,249|
|TOTAL||||830,059|145,468|975,527|955,842|
|Net incoming resources before investment||||261,237|(1,990)|259,247|213,201|
|gains/(losses)||||||||
|Net gains/(losses)|on investments|||24,839||24,839|107,666|
|NET MOVEMENT|IN|FUNDS||286,076|(1,990)|284,086|320,867|
|RECONCILIATION|OF FUNDS:|||||||
|Total funds brought||forward||1,650,225|8,339|1,658,564|1,337,697|
|TOTAL FUNDS CARRIED FORWARD||||1,936,301|6p349|1,942,650|1,658,564|





## 

## 

## 

|||31.3.22|31.3.21|
|---|---|---|---|
||Notes|E|E|
|FIXED ASSETS||||
|Tangible assets||70,364|31,303|
|||70,364|31,303|
|CURRENT ASSETS||||
|Current asset investments|13|740,579|715,740|
|Debtors|14|191,762|190,673|
|Cash at bank||1,040,109|809,405|
|||1,972,450|1,715,818|
|CREDITORS||||
|Amounts<br>falling due within one year|15|(100p164)|(88,557)|
|NET CURRENT ASSETS||1,872,286|1,627,261|
|TOTAL ASSETS LESSCURRENT LIABILITIES||||
|||1,942,650|1,658,564|
|NET ASSETS||1,942,650|1,658,564|
|FUNDS|16|||
|Restricted<br>funds||6p349|8,339|
|Designated<br>funds||325,000|325,000|
|Unrestricted<br>funds||1,611,301|1,325,225|
|TOTAL FUNDS||1,942,650|1,658,564|





## 

## 

## 

||||31.3.22|31.3.21|
|---|---|---|---|---|
|||Notes|E|E|
|FIXED ASSETS|||||
|Tangible assets||11|68,565|30,498|
|Investments||12|1|1|
||||68,566|30,499|
|CURRENT ASSETS|||||
|Current asset investments||13|740,579|715,740|
|Debtors||14|217,887|194,645|
|Cash at bank|||1,010,402|802,119|
||||1,968,868|1,712,504|
|CREDITORS|||||
|Amounts<br>falling due within|one year|15|(91,828)|(84,439)|
|NET CURRENT ASSETS|||1,877,040|1,628,065|
|TOTAL ASSETS LESSCURRENT LIABILITIES|||||
||||1,945,606|1,658,564|
|NET ASSETS|||1,945,606|1,658,564|
|FUNDS||16|||
|Restricted<br>funds|||6,349|8,339|
|Designated<br>funds|||325,000|325,000|
|Unrestricted<br>funds|||1,614,257|1,325,225|
|TOTAL FUNDS|||1,945,606|1,658,564|





## 

||||31.3.22|31.3.21|
|---|---|---|---|---|
|||Notes|E|f|
|CASH FLOWS FROM|CHARITABLE ACTIVITIES||||
|Cash generated<br>from|activities||306,044|225,118|
|Net cash from charitable<br>activities|||306,044|225,118|
|CASH FLOWS FROM|INVESTING ACTIVITIES||||
|Purchase oftangible|fixed assets||(50,846)|(10,108)|
|Interest received|||345|798|
|Net cash from investing<br>activities|||(50,501)|(9,310)|
|Increase/(decrease)|in cash and cash||255,543|215,808|
|equivalents|||||
|Cash and cash equivalents<br>at start ofyear|||1,525,145|1,309,337|
|Cash and cash equivalents<br>at end ofyear||2|1,780,688|1,525,145|





## 

## 

||||||31.03.22|31.03.21|
|---|---|---|---|---|---|---|
||||||f|E|
|Surplus for the|year||||284,086|320,867|
|Depreciation<br>charges|||||11,785|8,099|
|Finance income|||||(345)|(798)|
||||||295,526|328,168|
|Decrease/(increase)||in trade and||other debtors|(1,089)|(127,752)|
|Increase/(decrease)||in trade and||other creditors|11,607|24,702|
|Cash generated|from||charitable|activities|306,044|225,118|



## 

## 

|Year|ended 31"March 2022|||
|---|---|---|---|
|||31.03.22|1.04.21|
|||E|f|
|Cash|and cash equivalents|1,780,688|1,525,145|
|Year|ended 31"March 2021|||
|||31.03.21|1.04.20|
||||E|
|Cash|and cash equivalents|1,525,145|1,309,337|





## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

|||31.03.22||31.03.21||
|---|---|---|---|---|---|
|||Group|Company|Group|Company|
|||E|E|E|E|
|Donations|and gifts|103,519|103,519|123,063|123,063|
|Legacies|received|283,384|283,384|14,950|14,950|
|||386,903|386,903|138,013|138,013|



## 

## 

||||31.03.22||31.03.21||
|---|---|---|---|---|---|---|
||||Group|Company|Group|Company|
||||E|E|E|E|
|NHS: East Lancashire|||||||
|Clinical Commission||Group|286,065|286,065|281,534|281,534|
|Continual<br>Care Funding|||123,492|123,492|130,052|130,052|
|NHSE Covid Funding|||143,478|143,478|334,568|334,568|
|Job Retention|Scheme|Grant|7,956|7,956|72,340|72,340|
|NHS England|ICS Pilot||||25,000|25,000|
|EMIS Grant|||8,000|8,000|7,750|7,750|
||||568,991|568,991|851,244|851,244|





## 

## 

|OTHER TRADING ACTIVITIES|||||
|---|---|---|---|---|
||31.03.22||31.03.21||
||Group|Company|Group|Company|
||E|E|E|E|
|Fund raising events|163,192|163,192|98,248|98,248|
|Retails sales|109,309|2,115|42,793|61|
||272p501|165,307|141,041|98,309|



## 

## 

|||||31.03.22|31.03.22||31.03.21|31.03.21|
|---|---|---|---|---|---|---|---|---|
||||Group|||Company|Group|Company|
||||E|||E|E||
|Investment<br>receivable||||345||345|798|798|
|||||345||345|798|798|
|n 2021,the investment|income included,|ENil ofrestricted||and|F798|ofunrestricted|funds.||
|TOTAL RESOURCES EXPENDED|||||||||
|||Raising|||Charitable||Total|Total|
|||Funds|||Activities||2022|2021|
|||E||||E|E|E|
|Costs directly allocated to activities:|||||||||
|Staff costs||65p915||||517,121|583,036|567,586|
|Agency staff||||||42,502|42,502|42,648|
|Advertising||||||202|202||
|Travel and motor|||418|||21,521|21p939|18,225|
|Event expenses||30p051|||||30,051|8,520|
|Trading purchases||||||1,451|1,451|36,185|
|Rent, rates and utilities||38,054||||25,350|63,404|55,050|
|Insurance|||401|||11,751|12,152|9,472|
|Training||||||802|802|1,505|
|Telephone|||745|||5,715|6,460|5,449|
|Depreciation —unrestricted|||852|||10,933|11,785|8,099|
|Repairs and renewals||4,546||||13,352|17,898|10,107|
|Stationery,<br>postage and printing|||37|||7,920|7,957|14,183|
|Miscellaneous||1.323||||23,417|24,740|19,228|
|Support costs (Note|7)|2,368||||148,780|151,148|159,585|
|||144,710|||830,817||975,527|955,842|



## 



## 

## 

|||Governance|Support|Total|Total|
|---|---|---|---|---|---|
||||Costs|2022|2021|
||||E|E|E|
|Support costs allocated|to activities:|||||
|Staff costs||130,369||130,369|141,897|
|Bank charges||2,368|3,092|5,460|4,049|
|Legal and professional|fees|10'883||10,883|9,505|
|Audit and accountancy|fees|4,436||4,436|4,134|
|||148,056|3,092|151p148|159,585|



## 

## 

|||31.3.22|31.3.21|
|---|---|---|---|
|||E|E|
|Depreciation<br>-owned assets||11,785|8,099|
|Auditor's|remuneration<br>for audit services|4,436|4,134|
|Operating|lease payments —land and building|53,698|49,346|
|NET OUTGOING<br>RESOURCES —COMPANY||||
|Net resources are stated after charging/(crediting):||||
|||31.3.22|31.3.21|
|||E|E|
|Depreciation<br>—owned assets||10,933|7,612|
|Auditor's|remuneration<br>for audit services|3,511|3,209|
|Operating|lease payments —land and buildings|25,350|25,065|



## 

## 

|||31.03.22||31.03.21||
|---|---|---|---|---|---|
|||Group|Company|Group|Company|
|||E|E|E|E|
|Wages|and salaries|647,583|586,853|637,575|601,997|
|Social|security costs|41,803|38,600|43,423|39,344|
|Other|pension costs|24,019|22,037|28,485|26,244|
|||713,405|647,490|709,483|667,585|





## 

||||31.03.22|||31.03.21||
|---|---|---|---|---|---|---|---|
|||Group||Company|Group||Company|
|Day therapy|||9|9||9|9|
|Hospice at home|||23|23||21|21|
|Family support|services||2|2||1|1|
|Administration|||7|7||7|7|
|Fund raising|||4|4||4|4|
|Hospice shops|||5|||5||
||||50|45||47|42|



## 

## 

## 

## 

||||31.3.22|31.3.21|
|---|---|---|---|---|
||||E|E|
|Income:|||||
|Donations|and legacies||386,903|138,013|
|Charitable|activities||568,991|851,244|
|Other trading||activities|165,307|98,309|
|Investments|||345|798|
|Contribution||from subsidiary||1,680|
|Expenses:|||||
|Raising funds|||(39,922)|(76,600)|
|Charitable|activities||(819p421)|(800,243)|
|Investment|gains / (losses)||24,839|107,666|
||||287'042|320,867|





## 

## 

|TANGIBLE FIXED ASSETS —GROUP|||||
|---|---|---|---|---|
||Leasehold|Equipment<br>&|Motor||
||Improvements|furniture|vehicles|Totals|
||E|E|f|E|
|COST|||||
|At 1st April 2021|30,457|122,608|77p540|230,605|
|Additions||50,846||50,846|
|Disposals|||||
|At 31st March 2022|30,457|173,454|77,540|281,451|
|DEPRECIATION|||||
|At 1st April 2021|30,154|91,608|77,540|199,302|
|Charge for year|303|11,482||11,785|
|Elimination<br>on disposal|||||
|At 31st March 2022|30p457|103,090|77,540|211,087|
|NET BOOK VALUE|||||
|At 31st March 2022||70,364||70,364|
|At 31st March 2021|303|31,000||31,303|
|TANGIBLE FIXEDASSETS —COMPANY|||||
||Leasehold|Equipment<br>&|Motor||
||Improvements|furniture|vehicles|Totals|
||E|f|f|E|
|COST|||||
|At 1st April 2021|11,640|113,403|77,540|202,583|
|Additions||49,000||49,000|
|Disposals|||||
|At 31st March 2022|11,640|162,403|77,540|251,583|
|DEPRECIATION|||||
|At 1st April 2021|11,640|82,905|77,540|172,085|
|Charge for year||10,933||10,933|
|Eliminated<br>on disposal|||||
|At 31stMarch 2022|11,640|93,838|77,540|183,018|
|NET BOOK VALUE|||||
|At 31stMarch 2022||68,565||68,565|
|At 31stMarch 2021||30,498||30,498|





## 

## 

|Details ofthe subsidiary|Details ofthe subsidiary|undertaking|undertaking|are as follows:|||||||
|---|---|---|---|---|---|---|---|---|---|---|
|~NN<br>II||||~P«I||I|||~PI*|I|
|||||Value of issued||shares held|||||
|Rossendale<br>Hospice Trading|||Limited|100/o Ordinary|||shares||Charity shops||
|CURRENT ASSET INVESTMENTS|||||||||||
||||||||||31.3.22|31.3.21|
||||||||||f|f|
|Market value at beginning|||ofyear||||||715P740|608,074|
|Additions<br>during the|year||||||||||
|Disposals during the year|||||||||||
|Net gain/ (loss) during||the|year||||||24,839|107,666|
|Market value at end|ofyear||||||||740,579|715,740|
|DEBTORS:AMOUNTS|FALLING DUE WITHIN ONE YEAR||||||||||
|||||||31.03.22|||31.03.21||
||||||Group|||Company|Group|Company|
||||||f|||f|f|f|
|Trade debtors|||||6,657|||6P657|20,856|20,856|
|Amounts<br>owed by|||||||||||
|subsidiary<br>undertaking||||||||35,050||49,485|
|Prepayments<br>and|||||||||||
|accrued income|||||166,574|||158P737|129,041|117,871|
|Other debtors|||||18,531|||17P443|40,776|6,433|
||||||191P762|||217,887|190,673|194,645|
|CREDITORS'.AMOUNTS||FALLING DUE WITHIN ONE|||YEAR||||||
|||||||31.03.22|||31.03.21||
||||||Group|||Company|Group|Company|
||||||f|||f|f|f|
|Trade creditors|||||11,301|||4,320|18,588|15,588|
|Accruals|||||46,926|||45,571|40,114|38,996|
|Deferred income|||||||||4,000|4,000|
|Other creditors|||||41,937|||41,937|25,855|25,855|
||||||100,164|||91,828|88,557|84,439|




## 

## 



||Unrestricted|Designated|Restricted|Total|
|---|---|---|---|---|
||funds|funds|funds|Funds|
||f|f|f|E|
|Fixed assets|64,653||5,711|70,364|
|Net current assets|1,546,648|325,000|638|1,872,286|
||1,611,301|325,000|6,349|1,942,650|
|ANALYSIS OF NET ASSETS BETWEEN FUNDS - COMPANY|||||
||Unrestricted|Designated|Restricted|Total|
||funds|funds|funds|Funds|
||E|f|f|f|
|Fixed assets|62'854||5,711|68,565|
|Net current assets|1,551p402|325,000|638|1,877p040|
||1,614,256|325,000|6,349|1,945,605|



## 

|||At 1.4.21|Net|At31.3.22|
|---|---|---|---|---|
||||movement<br>in||
||||funds||
||||f||
|Restricted funds|||||
|Fixed assets||7,701|(1,990)|5,711|
|NHSE Covid funding|||||
|Other donations||638||638|
|||8,339|(1,990)|6,349|
|Unrestricted<br>funds|||||
|Designated funds:|||||
|Service Development|in the Community|45,000||45,000|
|Hospice at Home legacy||280,000||280,000|
|General funds||1p325,225|286,076|1,611,301|
|||1,650,225|286p076|1936p301|
|TOTAL FUNDS||1,658,564|284,086|1,942,650|






## 

## 

## 



## 

## 

## 

## 

|Group|||||
|---|---|---|---|---|
||Land and buildings||Other operating|leases|
||31.03.22|31.03.21|31.03.22|31.03.21|
|||E|E|E|
|Expiring:|||||
|Within one year|13,750|26,250|||
|Between one and five years|14,400||||
|More than five years|25,350|25,350|||
||53,500|51,600|||
|Company|||||
||l.and and buildings||Other operating|leases|
||31.03.22|31.03.21|31.03.22|31.03.21|
||E|E|E|E|
|Expiring:|||||
|Within one year|||||
|Between one and five years|||||
|More than five years|25,350|25,350|||
||25,350|25,350|||





|||31.3.22|31.3.21|
|---|---|---|---|
|||E|E|
|INCOMING<br>RESOURCES||||
|Donations<br>and gifts||103,519|123,063|
|Iegacies received||283,384|14,950|
|Fund raising events||163,192|98,248|
|Retail sales||109,309|42,793|
|Interest receivable||345|798|
|Clinical Commission<br>Group||286,065|281,534|
|Continual<br>Care Services||123,492|130,052|
|NHSE Covid Funding||143,478|334,568|
|Job Retention<br>Scheme|Grant|7,956|72,340|
|NHS England<br>ICS Pilot|||25,000|
|EMIS Grant||8,000|7,750|
|Other income||6,034|37,947|
|Total incoming resources||1,234,774|1,169,043|
|RESOURCES EXPENDED||||
|Staff costs||713,405|709,483|
|Agency staff||42,502|42,648|
|Advertising||202||
|Travel and motor||21,939|18,225|
|Specific event expenses||30,051|8,520|
|Trading purchases||1,451|36,185|
|Rent, rates and utilities||63,404|55,050|
|Insurance||12,152|9,472|
|Training||802|1,505|
|Telephone||6,460|5,449|
|Depreciation||11,785|8,099|
|Repairs and renewals||17,898|10,107|
|Stationery,<br>postage and printing||7,957|14,183|
|Miscellaneous||24,740|19,228|
|Bank charges||5,460|4,049|
|Legal and professional|fees|10,883|9,505|
|Audit and accountancy||4,436|4,134|
|Total resources expended||975,527|955,842|
|Net incoming resources before investments||259,247|213,201|
|Gains / (losses) on investments||24,839|107,666|
|Net incoming resources||284,086|320,867|